The proliferation of pancreatic cancer cells was notably enhanced by CASC19 overexpression (Fig. 2D) and reduced by downregulation of CASC19, as measured by MTT assay (Fig. 2E). Here, CASC19 is linked to familial pancreatic carcinoma.